MedTrace Logo

Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.

NCT00287534 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 1059

Last updated 2009-06-09

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy and tolerability of 3 years treatment with anastrozole after a prior 2 years' treatment with tamoxifen versus 5 years treatment with tamoxifen in postmenopausal women with early breast cancer

Conditions

Interventions

DRUG

Anastrozole

oral

DRUG

Tamoxifen

oral

Sponsors & Collaborators

  • German Adjuvant Breast Cancer Group

    collaborator OTHER

  • AstraZeneca

    lead INDUSTRY

Principal Investigators

  • Manfred Kaufmann, MD · German Adjuvant Breast Cancer Group

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-11-30
Completion
2004-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00287534 on ClinicalTrials.gov